Advertise with us
Clinical Group

International Journal of Radiology and Radiation Oncology

    Abstract Open Access
    Case Report PTZAID: IJRRO-3-120

    Combination of Thrombolysis and Glycoprotein IIb/IIIa Inhibition in Chronic Peripheral Thrombosis: A Case Report

    Mubin I Syed*, Ryan Gallagher, Zeshan Hussain, Azim Shaikh, Philip J Cain, Kamal Morar, Matthew Sebastian, Robert Tyrrell, Allen Guehl and Ronald Erdelyi

    Currently, many interventionalists employ either tissue plasminogen activator (alteplase, Genentech,San Francisco, CA), or recombinant plasminogen activator (reteplase, Chiesi USA, Inc., Cary, NC), for peripheral thrombolysis. Further, combination therapy utilizing a thrombolytic agent and a glycoprotein IIb/IIIa receptor antagonist has been proposed as a way to overcome the limitations of thrombolytic therapy alone by reducing the duration of infusion, preventing rethrombosis, and improving the efficacy of thrombolysis. The following report discusses a patient with stenoses in the distal right posterior tibial artery. The patient underwent percutaneous transluminal angioplasty along with tissue plasminogen activator infusion therapy. Initially, the tissue plasminogen activator infusion reduced pain. However,an embolic occlusion to the distal right lateral plantar artery led to recurrence of pain. Due to failure of thrombolytic monotherapy using tissue plasminogen activator, a combined treatment of eptifibatide (Integrilin, Cor Therapeutics and Schering-Plough) and tissue plasminogen activator infused intraarterially was initiated. In this report, the successful clinical use of combination therapy has been demonstrated after failed intra-arterial tissue plasminogen activator infusion monotherapy. The use of purely intra-pedal intra-arterial eptifibatide is novel and should be studied in randomized trials to establish efficacy. Furthermore, we have shown that failure of monotherapy to treat occlusions can be recovered through the use of combination therapy.

    Published on: Jan 24, 2017 Pages: 4-6

    Full Text PDF Full Text HTML DOI: 10.17352/ijrro.000020

    Advertisements

    Google Ads

    Peertechz @Social

    Peertechz Tweets

    Case Reports

    Pinterest on IJRRO